SCHEMBL6804824

SCHEMBL6804824

Cc1ccc(-c2ccccc2C(=O)Nc2ccc3c(c2)CCN3C(=O)Cc2csc(C)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.49
CASP2 P42575 1/20 0.49
MAPT P10636 6/20 0.46
NPC1 O15118 5/20 0.46
RAB9A P51151 5/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
TP53 P04637 2/20 0.46
ALDH1A1 P00352 2/20 0.43
POLB P06746 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
LMNA P02545 1/20 0.42
STAT1 P42224 2/20 0.42
CREBBP Q92793 1/20 0.42
KDM4E B2RXH2 1/20 0.42
AVPR2 P30518 6/20 0.42
AVPR1A P37288 3/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
KLK7 P49862 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6803455 0.92 MAPT (0.44) CASP3CASP2MAPTNPC1RAB9A
SCHEMBL6804506 0.92 MTTP (0.48) CASP3CASP2TP53LMNAKDM4E
SCHEMBL6801575 0.91 MAPT (0.53) CASP3CASP2MAPTNPC1RAB9A
SCHEMBL6800199 0.90 MAPT (0.44) CASP3CASP2MAPTNPC1RAB9A
SCHEMBL6798990 0.89 MAPT (0.43) CASP3CASP2MAPTNPC1RAB9A
SCHEMBL6804945 0.87 MAPT (0.46) MAPTNPC1RAB9ASMN1; SMN2TP53
SCHEMBL6668503 0.86 EIF2AK3 (0.51) MAPTNPC1RAB9ASMN1; SMN2TP53
SCHEMBL6803357 0.85 EIF2AK3 (0.46) MAPTNPC1RAB9ASMN1; SMN2TP53
Hydrochloric Acid SCHEMBL6664580 0.85 EIF2AK3 (0.50) MAPTNPC1RAB9ASMN1; SMN2TP53
Hydrochloric Acid SCHEMBL6804708 0.85 EIF2AK3 (0.45) MAPTNPC1RAB9ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157866-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157866-A1 Amide compounds APOB, NR1H2, NR1H3 CASP3 3603/4885CASP2 2284/4885MAPT 4047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.